title: In vitro infection of human placental trophoblast by wild-type vaccinia virus and recombinant virus expressing HIV envelope glycoprotein.
abstract: Short-time (< or = 7 days) cultures of trophoblast mononuclear cells isolated from term placentae were challenged with vaccinia virus. Cytopathic effects were induced in crude placental cell preparations as well as in cultures established after negative immunosorting of major histocompatibility complex class I epitope-expressing cells, i.e. cultures exclusively derived from villous cytotrophoblast according to our present state of knowledge. The trophoblast in vitro supported a full replicative cycle of both wild-type viruses and a recombinant clone serving as a vector for the human immunodeficiency virus type 1 envelope gene. Results may shed light on mechanisms involved in the rarely observed foetal damage caused by smallpox vaccination during pregnancy.
authors: Department of Virus & Cancer, Danish Cancer Society, Arhus.
authors: N
authors: N
authors: Nørskov-Lauritsen
authors: V
authors: V
authors: Zachar
authors: P M
authors: PM
authors: Petersen
authors: H
authors: H
authors: Hager
authors: G
authors: G
authors: Aboagye-Mathiesen
authors: P
authors: P
authors: Ebbesen
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000096:biosynthesis; D003588:Cytopathogenic Effect, Viral; D015686:Gene Products, env / Q000235:genetics*; D005822:Genetic Vectors; D015699:HIV Envelope Protein gp120 / Q000032:analysis; D019302:HIV Envelope Protein gp160; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D011498:Protein Precursors / Q000235:genetics*; D014327:Trophoblasts / Q000378:metabolism / Q000382:microbiology*; D014407:Tumor Cells, Cultured; D014614:Vaccines, Synthetic; D014616:Vaccinia virus / Q000235:genetics / Q000502:physiology*; D014709:Vero Cells
chemical_list: D006063:Chorionic Gonadotropin; D015686:Gene Products, env; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors; D014614:Vaccines, Synthetic